These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18175088)

  • 21. [Usefulness of alpha 2-adrenoceptor agonists and practical problems associated with their use in clinical anesthesia--II. Effects in regional anesthesia and analgesic effects for pain relief].
    Nishikawa T; Dohi S
    Masui; 1997 Jan; 46(1):64-72. PubMed ID: 9028085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etomidate and other non-barbiturates.
    Vanlersberghe C; Camu F
    Handb Exp Pharmacol; 2008; (182):267-82. PubMed ID: 18175096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informed development of drugs acting at family B G protein-coupled receptors.
    Miller LJ
    Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
    Parthier C; Reedtz-Runge S; Rudolph R; Stubbs MT
    Trends Biochem Sci; 2009 Jun; 34(6):303-10. PubMed ID: 19446460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling mechanisms of GPCR ligands.
    Strange PG
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):196-202. PubMed ID: 18283607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids and sensory nerves.
    Stein C; Zöllner C
    Handb Exp Pharmacol; 2009; (194):495-518. PubMed ID: 19655116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic use of release-modifying drugs.
    Langer SZ
    Handb Exp Pharmacol; 2008; (184):561-73. PubMed ID: 18064425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A; Tovey SC; Brighton PJ; Willars GB
    Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications.
    Durieux ME
    Anesthesiology; 1996 Jan; 84(1):173-89. PubMed ID: 8572331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging molecular mechanisms of general anesthetic action.
    Hemmings HC; Akabas MH; Goldstein PA; Trudell JR; Orser BA; Harrison NL
    Trends Pharmacol Sci; 2005 Oct; 26(10):503-10. PubMed ID: 16126282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anesthetics drug pharmacodynamics.
    Bischoff P; Schneider G; Kochs E
    Handb Exp Pharmacol; 2008; (182):379-408. PubMed ID: 18175101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
    Höcker J; Böhm R; Meybohm P; Gruenewald M; Renner J; Ohnesorge H; Scholz J; Bein B
    J Pharm Pharmacol; 2009 Jul; 61(7):901-10. PubMed ID: 19589232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.
    Zürn A; Zabel U; Vilardaga JP; Schindelin H; Lohse MJ; Hoffmann C
    Mol Pharmacol; 2009 Mar; 75(3):534-41. PubMed ID: 19106230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anesthesia drugs, immunity, and long-term outcome.
    Homburger JA; Meiler SE
    Curr Opin Anaesthesiol; 2006 Aug; 19(4):423-8. PubMed ID: 16829725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha2-agonists as analgesic agents.
    Giovannoni MP; Ghelardini C; Vergelli C; Dal Piaz V
    Med Res Rev; 2009 Mar; 29(2):339-68. PubMed ID: 18680204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversifying the repertoire of G protein-coupled receptors through oligomerization.
    Park PS; Palczewski K
    Proc Natl Acad Sci U S A; 2005 Jun; 102(25):8793-4. PubMed ID: 15956197
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic dissection of alpha2-adrenoceptor functions in adrenergic versus nonadrenergic cells.
    Gilsbach R; Röser C; Beetz N; Brede M; Hadamek K; Haubold M; Leemhuis J; Philipp M; Schneider J; Urbanski M; Szabo B; Weinshenker D; Hein L
    Mol Pharmacol; 2009 May; 75(5):1160-70. PubMed ID: 19251826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.